Phase 2 trial of BCNU plus irinotecan in adults with malignant glioma

This publication has 31 references indexed in Scilit:

• Phase 1 trial of irinotecan plus BCNU in patients with progressive or recurrent malignant glioma
  Neuro-Oncology, 2004
• Phase III Study Comparing Three Cycles of Infusional Carmustine and Cisplatin Followed by Radiation Therapy With Radiation Therapy and Concurrent Carmustine in Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme: Eastern Cooperative Oncology Group Trial 2394
  Journal of Clinical Oncology, 2003
• Efficacy of topoisomerase I inhibitors, topotecan and irinotecan, administered at low dose levels in protracted schedules to mice bearing xenografts of human tumors
  Cancer Chemotherapy and Pharmacology, 1995
• Camptothecin analogues: studies from The Johns Hopkins Oncology Center
  Cancer Chemotherapy and Pharmacology, 1994
• Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarrazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report
  International Journal of Radiation Oncology*Biology*Physics, 1990
• Randomized trial of three chemotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma
  Journal of Neurosurgery, 1989
• Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma
  International Journal of Radiation Oncology*Biology*Physics, 1989
• Phase III comparison of BCNU and the combination of procarbazine, CCNU, and vincristine administered after radiotherapy with hydroxyurea for malignant gliomas
  Journal of Neurosurgery, 1985
• Prediction of BCNU Pulmonary Toxicity in Patients with Malignant Gliomas
  New England Journal of Medicine, 1980
• Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas
  Journal of Neurosurgery, 1978